THBS1 and acute coronary syndrome: A clinical study from Beijing further associated elevated plasma TSP1 levels with worse outcomes in acute coronary syndrome (ACS), including higher mortality, recurrent ischemia, and in-hospital heart failure, highlighting its potential as a prognostic biomarker [45].